134 related articles for article (PubMed ID: 15862665)
1. Quantitative analysis of amorphous content of lactose using CCD-Raman spectroscopy.
Niemelä P; Päällysaho M; Harjunen P; Koivisto M; Lehto VP; Suhonen J; Järvinen K
J Pharm Biomed Anal; 2005 Apr; 37(5):907-11. PubMed ID: 15862665
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the amorphous content of lactose by solution calorimetry and Raman spectroscopy.
Katainen E; Niemelä P; Harjunen P; Suhonen J; Järvinen K
Talanta; 2005 Nov; 68(1):1-5. PubMed ID: 18970276
[TBL] [Abstract][Full Text] [Related]
3. Approaches to determine the enthalpy of crystallisation, and amorphous content, of lactose from isothermal calorimetric data.
Dilworth SE; Buckton G; Gaisford S; Ramos R
Int J Pharm; 2004 Oct; 284(1-2):83-94. PubMed ID: 15454300
[TBL] [Abstract][Full Text] [Related]
4. Measurement of lactose crystallinity using Raman spectroscopy.
Murphy BM; Prescott SW; Larson I
J Pharm Biomed Anal; 2005 Jun; 38(1):186-90. PubMed ID: 15907639
[TBL] [Abstract][Full Text] [Related]
5. The development of DMA for the detection of amorphous content in pharmaceutical powdered materials.
Royall PG; Huang CY; Tang SW; Duncan J; Van-de-Velde G; Brown MB
Int J Pharm; 2005 Sep; 301(1-2):181-91. PubMed ID: 16026947
[TBL] [Abstract][Full Text] [Related]
6. The potential of high speed DSC (hyper-DSC) for the detection and quantification of small amounts of amorphous content in predominantly crystalline samples.
Saunders M; Podluii K; Shergill S; Buckton G; Royall P
Int J Pharm; 2004 Apr; 274(1-2):35-40. PubMed ID: 15072780
[TBL] [Abstract][Full Text] [Related]
7. Considerations on the quantitative analysis of apparent amorphicity of milled lactose by Raman spectroscopy.
Pazesh S; Lazorova L; Berggren J; Alderborn G; Gråsjö J
Int J Pharm; 2016 Sep; 511(1):488-504. PubMed ID: 27397869
[TBL] [Abstract][Full Text] [Related]
8. Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction.
Chieng N; Rehder S; Saville D; Rades T; Aaltonen J
J Pharm Biomed Anal; 2009 Jan; 49(1):18-25. PubMed ID: 19081220
[TBL] [Abstract][Full Text] [Related]
9. Using the low-frequency Raman spectroscopy to analyze the crystallization of amorphous indomethacin.
Hédoux A; Paccou L; Guinet Y; Willart JF; Descamps M
Eur J Pharm Sci; 2009 Sep; 38(2):156-64. PubMed ID: 19591926
[TBL] [Abstract][Full Text] [Related]
10. Compaction of lactose drug mixtures: quantification of the extent of incompatibility by FT-Raman spectroscopy.
Flemming A; Picker-Freyer KM
Eur J Pharm Biopharm; 2008 Mar; 68(3):802-10. PubMed ID: 17826048
[TBL] [Abstract][Full Text] [Related]
11. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
Timmermann IL; Steckel H; Trunk M
Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
[TBL] [Abstract][Full Text] [Related]
12. Detection of low levels of amorphous lactose using H/D exchange and FT-Raman spectroscopy.
Whiteside PT; Luk SY; Madden-Smith CE; Turner P; Patel N; George MW
Pharm Res; 2008 Nov; 25(11):2650-6. PubMed ID: 18769874
[TBL] [Abstract][Full Text] [Related]
13. Determination of amorphous content in the pharmaceutical process environment.
Savolainen M; Jouppila K; Pajamo O; Christiansen L; Strachan C; Karjalainen M; Rantanen J
J Pharm Pharmacol; 2007 Feb; 59(2):161-70. PubMed ID: 17270070
[TBL] [Abstract][Full Text] [Related]
14. Advanced calibration strategy for in situ quantitative monitoring of phase transition processes in suspensions using FT-Raman spectroscopy.
Chen ZP; Fevotte G; Caillet A; Littlejohn D; Morris J
Anal Chem; 2008 Sep; 80(17):6658-65. PubMed ID: 18665607
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of paracetamol polymorphs in powder mixtures by FT-Raman spectroscopy and PLS regression.
Kachrimanis K; Braun DE; Griesser UJ
J Pharm Biomed Anal; 2007 Jan; 43(2):407-12. PubMed ID: 16935450
[TBL] [Abstract][Full Text] [Related]
16. Validation of an in-line Raman spectroscopic method for continuous active pharmaceutical ingredient quantification during pharmaceutical hot-melt extrusion.
Saerens L; Segher N; Vervaet C; Remon JP; De Beer T
Anal Chim Acta; 2014 Jan; 806():180-7. PubMed ID: 24331054
[TBL] [Abstract][Full Text] [Related]
17. Crystallization of bulk samples of partially amorphous spray-dried lactose.
Darcy P; Buckton G
Pharm Dev Technol; 1998 Nov; 3(4):503-7. PubMed ID: 9834953
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of transmission Raman spectroscopy for rapid quantitative analysis of intact multi-component pharmaceutical capsules.
Hargreaves MD; Macleod NA; Smith MR; Andrews D; Hammond SV; Matousek P
J Pharm Biomed Anal; 2011 Feb; 54(3):463-8. PubMed ID: 20947277
[TBL] [Abstract][Full Text] [Related]
19. Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and near-infrared spectroscopy.
Heinz A; Savolainen M; Rades T; Strachan CJ
Eur J Pharm Sci; 2007 Nov; 32(3):182-92. PubMed ID: 17716878
[TBL] [Abstract][Full Text] [Related]
20. Dispersive Raman Spectroscopy for Quantifying Amorphous Drug Content in Intact Tablets.
Wabuyele BW; Sotthivirat S; Zhou GX; Ash J; Dhareshwar SS
J Pharm Sci; 2017 Feb; 106(2):579-588. PubMed ID: 27938895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
